AXIN2 and breast carcinoma: Ren et al. [52] revealed that AXIN2 was a target of miR-454-3p and was involved in the activation of Wnt/β-catenin signaling, which can be suppressed by miR-454-3p to promote metastasis and the stemness of breast cancer.